|
|
Volumn 31, Issue 4, 2013, Pages 223-224
|
|
Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
GEMCITABINE;
IBRITUMOMAB TIUXETAN;
IFOSFAMIDE;
LENALIDOMIDE;
LEVOLEUCOVORIN;
METHOTREXATE;
MITOXANTRONE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
AGED;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
GERIATRIC DISORDER;
HUMAN;
LARGE CELL LYMPHOMA;
LETTER;
LONG TERM CARE;
MAINTENANCE THERAPY;
MULTIPLE CYCLE TREATMENT;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
AGED;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MAINTENANCE CHEMOTHERAPY;
MIDDLE AGED;
REMISSION INDUCTION;
THALIDOMIDE;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 84889004860
PISSN: 02780232
EISSN: 10991069
Source Type: Journal
DOI: 10.1002/hon.2049 Document Type: Letter |
|
Times cited : (27)
|
|
References (5)
|
